Protalix Biotherapeutics Inc Capital Reinvestment Ratio
Protalix Biotherapeutics Inc capital reinvestment ratio. Protalix Biotherapeutics Inc (PLX) has a Capital Reinvestment Ratio of 0.61x as of December 2025, meaning it reinvests 1% of its operating cash flow ($2.03 Million) in capital expenditures ($1.24 Million). Check total reinvestment intensity of Protalix Biotherapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Protalix Biotherapeutics Inc (2009–2024)
Capital reinvestment ratio of Protalix Biotherapeutics Inc from 2009 to 2024. This chart tracks Protalix Biotherapeutics Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore PLX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Protalix Biotherapeutics Inc Capital Reinvestment Ratio by Year (2009–2024)
Protalix Biotherapeutics Inc capital reinvestment ratio by year from 2009 to 2024. For the full cash flow conversion analysis, see Protalix Biotherapeutics Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.15x | $8.67 Million | $1.28 Million | ▼ -95.5% |
| 2012 | 3.26x | $635.00K | $2.07 Million | ▲ +2236.8% |
| 2009 | 0.14x | $44.45 Million | $6.20 Million | — |